Although two other studies have investigated the role of CDKN2B-AS1 in RCC and found as well that it is overexpressed22,23, they were limited to verify the effects of CDKN2B-AS1 in vitro experiments, and did not discuss the reasons for the upregulation of it. The gene discussed is CDKN2B; the disease is renal cell carcinoma.